Table 4.
Proportional reporting ratios in completed primary series.
| Symptoms | Completed primary series | |||
|---|---|---|---|---|
| Specific AEs of COVID-19 vaccines | PRR | 95% CIL | 95% CIH | |
| Hearing loss | 4,319 | 1.554 | 1.487 | 1.625 |
| Tinnitus (Ringing in the ears) | 12,338 | 2.343 | 2.275 | 2.413 |
| Ear infections (Otitis Media) | 563 | 0.227 | 0.207 | 0.248 |
| Meniere’s disease | 82 | 1.945 | 1.382 | 2.736 |
| Vestibular neuronitis | 98 | 1.217 | 0.924 | 1.603 |
| Dizziness or vertigo | 71,255 | 1.629 | 1.612 | 1.647 |
| Sinusitis | 1,333 | 0.832 | 0.777 | 0.891 |
| Rhinitis (Allergic and Non-allergic) | 126 | 0.056 | 0.047 | 0.067 |
| Epistaxis | 2,085 | 1.605 | 1.506 | 1.712 |
| Anosmia | 3,652 | 3.167 | 2.983 | 3.363 |
| Nasal polyps | 15 | 1.956 | 0.879 | 4.355 |
| Snoring or difficulty breathing through the nose and sleep apnea | 494 | 0.205 | 0.186 | 0.225 |
| Allergies | 5,983 | 0.251 | 0.244 | 0.258 |
| Tonsillitis | 73 | 0.491 | 0.375 | 0.642 |
| Laryngitis | 135 | 0.332 | 0.275 | 0.401 |
| Vocal cord polyps and nodules | 27 | 1.101 | 0.659 | 1.837 |
| Laryngopharyngeal reflux (Acid Reflux) | 337 | 2.632 | 2.187 | 3.168 |
| Epiglottitis | 8 | 0.348 | 0.159 | 0.759 |
| Pharyngitis | 3,730 | 0.573 | 0.551 | 0.596 |
| Any IR | 106,653 | |||
| Sample size | 226,593,618 | |||
Data are from the VAERS and CDC Covid-19 vaccinations data tracker through to August 30, 2023. PRR, proportional reporting ratio.